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Abstract
Inhibitor of differentiation protein-2 (Id2) is a dominant negative helix-loop-helix (HLH) protein, and a positive regulator of
proliferation, in various cells. The N-terminal region of Id2 contains a consensus cdk2 phosphorylation sequence SPVR,
which may be involved with the induction of apoptosis, at least in myeloid 32d.3 cells. However, the role of Id2
phosphorylation at serine 5 in skeletal muscle cells is unknown. The objective of this study was to determine if the
phosphorylation of Id2 at serine 5 alters its cellular localization and its role in apoptosis in C2C12 myoblasts. Overexpression
of wild type Id2 decreased MyoD protein expression, which corresponded to the increased binding of Id2 to basic HLH
proteins E47 and E12. Bromodeoxyuridine incorporation was significantly decreased by the overexpression of phospho-
ablated Id2 (S5A); conversely, overexpression of wild type Id2 increased cellular proliferation. The subcellular localization of
Id2 and phospho-mimicking Id2 (S5D) were predominantly nuclear compared to S5A. The decreased nuclear localization of
S5A corresponded to a decrease in cellular proliferation, and an increase in apoptosis. These data suggest that
unphosphorylated Id2 is primarily localized in the cytosol, where it is growth suppressive and potentially pro-apoptotic.
These results imply that reducing unphosphorylated Id2 may improve the pool of myoblasts available for differentiation by
increasing proliferation and inhibiting apoptosis.
Citation: Butler DC, Haramizu S, Williamson DL, Alway SE (2009) Phospho-Ablated Id2 Is Growth Suppressive and Pro-Apoptotic in Proliferating Myoblasts. PLoS
ONE 4(7): e6302. doi:10.1371/journal.pone.0006302
Editor: Mikhail V. Blagosklonny, Roswell Park Cancer Institute, United States of America
Received December 16, 2008; Accepted June 11, 2009; Published July 17, 2009
Copyright:  2009 Butler et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by National Institutes of Health: National Institute on Aging grant R01 AG021530. Flow cytometry studies were supported in
part by grants RR020866 and RR16440 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: salway@hsc.wvu.edu
¤ Current address: Wadsworth Center NYS DOH, David Axelrod Institute, Albany, New York, United States of America
Introduction
Myogenesis requires that muscle precursor cells (e.g. satellite
cells), or myoblasts, undergo proliferation, followed by cell-cycle
exit. This is followed by myogenic differentiation, and finally cell
fusion into multinucleated myotubes then myofibers. Skeletal
muscle growth and regeneration/repair are critically dependent
on having an adequate pool of muscle precursor cells or myoblasts.
Consequently loss of myoblasts during the initial stages of
myogenesis limit or prevent muscle growth or in aging, may
contribute to sarcopenia by reducing the ability to replace muscle
mass during normal protein turnover [1]. Therefore, the
identification and characterization of important proteins that
regulate the expansion and survival of myoblasts are important for
both increasing our understanding of myogenesis, but also for
identifying strategies that will reduce the loss of muscle mass that
occurs with aging and disease.
While the majority of muscle precursor cells/myoblasts exit the
cell cycle and undergo terminal differentiation during myogenesis
and muscle repair/growth, ,30% of differentiating myoblasts
undergoes cell death during differentiation [2,3]. Interestingly,
signaling pathways required for the initiation and execution of
programmed cell death, or apoptosis, are activated during
myogenesis [4,5]. For example, caspase 3 is not only activated
during myogenesis, but also its activity is required for the initiation
of myogenic differentiation [6,7]. The mechanism by which the
majority of muscle cells undergo caspase-dependent differentiation
but escapes caspase-dependent or caspase-independent apoptosis
is not clear.
Control of apoptosis in myoblast proliferation and differentiation
is critical for development and muscle repair/growth. We propose
that inhibitor of differentiation (Id) protein may play roles in both
regulating proliferation/differentiation and apoptosis in skeletal
muscle cells. The Id family consists of helix-loop-helix proteins
(HLH) that act as negative regulators of cell differentiation in many
cell types including skeletal muscle [8–11]. Id proteins were
identified because of their sequence homology to the second
amphipathic helix shared by other basic HLH (bHLH) proteins
such as MyoD, E47, and E12 [12]. Homodimers and heterodimers
of bHLH proteins regulate the transcription of targeted genes such
as muscle creatine kinase(MCK) by binding to a palindromicE-box
motif, CANNTG [9,12,13]. Id proteins lack the basic N-terminal
region needed for DNA binding and inhibit myogenic differenti-
ation by sequestering bHLH proteins E47 and E12.
The levels of Id proteins are high during proliferation and
decrease prior to the onset of terminal differentiation in many cell
types [12,14,15]. Enforced overexpression of Id genes has been
shown to suppress myogenic differentiation, and the expression of
Id genes is rapidly increased when quiescent cells are stimulated
with serum [10,15].
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Id2, Id3, and Id4 share a conserved amino acid sequence SPVR,
which is a phosphorylation target of cyclin E-cdk2 and cyclin A-
cdk2 kinases. Id2 phosphorylation on serine 5 by cyclin A/cdk2
has been shown to restore E12/E12 and E12/MyoD binding to
DNA [15]. Interestingly, phospho-ablated Id2 mutants where
serine 5 has been mutated to an alanine are growth inhibitory in
fibroblasts, smooth muscle cells and osteosarcoma cell lines
[15,16], although it is not known if this is the case in myoblasts.
Ectopic overexpression of Id2 promotes S-phase entry in
smooth muscle cells [16]. Conversely, treatment with antisense
oligonucleotides complementary to Id2 inhibits cell cycle progres-
sion in serum stimulated fibroblasts [15]. In human fibroblasts and
neuroblastoma cell lines, Id2 promotes G1-S progression by
binding to the active, hypo-phosphorylated, form of retinoblasto-
ma protein pRb [17–19]. Rb family proteins p107 and p130 are
also antagonized by Id2 [20].
Id2 overexpression has also been linked to apoptosis in various
cell lines [8]. In 32D.3 myeloid progenitor cells, the N-terminal
region of Id2 is able to induce apoptosis independent of its HLH
function [21]. In aged rodent skeletal muscle, where Id2 levels are
elevated, there is a positive correlation between Id2 and pro-
apoptotic proteins Bax and caspase 9 [22].
Previous data show important roles for apoptosis in skeletal
muscle adaptations including loss of skeletal muscle during aging
[23–25]. We have previously speculated that the subcellular
localization of Id2 may be important in regulating apoptosis in
skeletal muscle [26,27]. Id2 cytoplasmic levels are elevated during
conditions of atrophy in skeletal muscle, and positively correlated
to proteins associated with the intrinsic pathway of cell death
[26,27]. Phospho-ablated mutants of Id2 at serine 5 are primarily
localized to the cytoplasm in primary rat aortic smooth muscle
cells [16], although it is not known if this is also the case in skeletal
muscle cells. Furthermore, the role of Id2 phosphorylation at
serine 5 is unknown in skeletal muscle and myogenic cell lines. In
this study we tested the hypothesis that Id2 phosphorylation at
serine 5 regulates apoptosis and cell cycle progression in
myoblasts.
Results
Phospho-ablated Id2 inhibits G1/S transition
The manner in which phosphorylated and phospho-ablated Id2
affected myoblast proliferation was measured by bromodeoxyur-
idine (BrdU) incorporation into S-phase of the cell cycle
(Figure 1A). S-phase myoblasts were determined from flow
cytometric analysis of BrdU expression (y-axis) and DNA content
(x-axis). Overexpression of Id2:GFP resulted in a significant
increase in the percentage of BrdU positive cells (Figure 1B)
compared to all other groups. Conversely, overexpression of
S5A:GFP resulted in a significant decrease in BrdU positive cells.
Phospho-ablated Id2 is pro-apoptotic in C2C12
myoblasts
To determine if the apoptotic role of Id2 is determined by the
phosphorylation status of this protein, C2C12 myoblasts were
Figure 1. Phospho-ablated Id2 reduces BrdU incorporation in myoblasts. Twenty four hours after transfection, the myoblasts were pulsed
with BrdU, and subjected to flow cytometric analysis. (A) Representative dot plot of Id2:GFP (left) and S5A:GFP (right). Y-axis=BrdU-Alexa 488 MFI. X-
axis=FL2-Area. The upper right quadrant contains cells that are S-phase/BrdU positive. G0/G1 and G2/M cell populations are determined by MFI of
7AAD intercalating into the DNA. (B) Summary of cell cycle data. [*, Id2:GFP and S5A:GFP are significantly different from all groups (p,0.05)].
doi:10.1371/journal.pone.0006302.g001
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harvested 24 hours after transfection and analyzed for Annexin V
expression (Figure 2). The cells’ surface expression of phosphati-
dylserine is a hallmark of cellular death associated with apoptosis
[28]. Viable cells are Annexin V negative and 7-amino-
actinomycin D (7AAD) negative. Cells in the early phases of cell
death are Annexin V positive and 7AAD-negative, and necrotic
cells are Annexin V positive and 7AAD-positive (Figure 2A).
Although transfection per se did result in a low level of apoptosis as
shown by an elevation in Annexin V positive cells (Figure 2A), a
less sensitive TdT-mediated dUTP nick end labeling (TUNEL)
assay, which measures the free 39OH end of DNA, did not show
an increase in the frequency of apoptotic cells in the vector-only
group (Figure 2B). In contrast, overexpression of phospho-ablated
Id2 (i.e., S5A) resulted in a significant increase in the percentage of
Annexin V positive myoblasts (Figure 2A) as well as an increase in
the percentage of TUNEL positive myoblasts (Figure 2B). Because
other processes such as necrosis and DNA repair result in free
39OH production, caspase 3 and caspase 8 activities were
measured to confirm apoptotic signaling in Id2S5A transfected
cells. Overexpression of Id2:F, S5A:F, and S5D:F resulted in a
significant increase of caspase 3 activity compared to CON and
EV:F (Figure 2D); however, caspase 3 activity was significantly
higher in S5A:F transfected myoblasts than all other groups.
Overexpression of S5A:F resulted in an increase of caspase 8
activity (Figure 2C) compared to CON, EV:F, and Id2:F
transfected myoblasts.
Wild-type Id2, phospho-ablated Id2 (S5A), and phospho-
mimicking Id2 (S5D) successfully bind to E47/E12
Id2-3XFlag fusion proteins were generated as a means for
identifying exogenous Id2 from endogenous Id2. To confirm that
flag positive myoblasts were also Id2 positive, transfected
Figure 2. Overexpression of phospho-ablated Id2 is pro-apoptotic. Control C2C12 myoblasts (CON) were transfected with, EV:F, Id2:F, S5A:F,
and S5D:F. Twenty-four hours after transfection, cells were assayed for apoptosis. (A) Summary of Annexin V data. [*, significantly different from CON
(p,0.05): #, significantly different from all groups (p,0.05).] Insert: Representative dot plots. (y-axis=7AAD, x-axis=AnnexinV PE). Cells in the lower
left quadrant are viable and 7AAD negative. Cells in the upper right quadrant were considered to be necrotic, and are annexin V positive and 7AAD
positive. Cells in the lower right quadrant are apoptotic, and Annexin V positive. (B) There is a significant increase (p,0.05) in the percent of cells
TUNEL positive in C2C12 myoblasts overexpressing phospho-ablated S5A:F than in all other groups. (C) Caspase 8 activity. [*, significantly different
from CON, EV:F (p,0.05) **, significantly different from CON (p,0.05) #, significantly different from Id2:F(p,0.05)]. (D) Caspase 3 activity assay. [*,
Significantly different from CON and EV (p,0.05): #, significantly different from all groups (p,0.05)].
doi:10.1371/journal.pone.0006302.g002
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(Supplement Figure S1). As expected, flag positive myoblasts were
also Id2 positive. There was approximately a 15 fold increase of
Id2 MFI in Id2:F, S5A:F, and S5D:F transfected myoblasts
compared to control (CON) and empty flag vector (EV:F) controls
(Supplement Figure S1). Id2 has been shown to preferentially bind
to the ubiquitously expressed E-proteins compared to tissue
restricted class B bHLH proteins such as MyoD [29]. Western
blots analysis were performed to determine if the overexpression of
Id2-3XFlag fusion proteins alter the protein expression of bHLH
proteins. The protein expression of MyoD and E47/E12 from
whole cell lysates was not altered by the overexpression of Id2:F,
S5A:F, and S5D:F compared to control cell lysates. Immunopre-
cipitation of anti-E47/E12 was performed to determine if the
phosphorylation of Id2 at serine 5 affects the ability of Id2 to
dimerize with E47/E12. The precipitates were probed with anti-
M2 flag antibody and there was a single band present at the
18 kDa molecular weight marker (Figure 3B). To confirm
endogenous Id2 binding to E-proteins, the E47/E12 precipitates
were probed with anti-Id2. As expected, endogenous Id2 was
bound to E47/E12 in CON and EV groups (Figure 3C). There
were non-specific bands migrating at 18 kDa in the lysates of
CON and EV:F; however, positive bands were not located in the
corresponding precipitates. Id2:F, S5A:F, and S5D:F groups had
bands migrating at 18 kDa, which correlated to the Id2 fusion
proteins. MyoD was not detected in any of the E47/E12
precipitates (data not shown).
Phospho-ablated Id2 is primarily localized in the cytosol
To determine the subcellular localization of Id2, nuclei were
isolated from C2C12 myoblasts transfected with EV:GFP,
Id2:GFP, S5A:GFP, and S5D:GFP (Figure 4A). There was a
significant increase in Id2 MFI in Id2:GFP and S5D:GFP
transfected cells over CON and EV:GFP control myoblasts;
however, there was a significant decrease in nuclear Id2 MFI in
S5A:GFP transfected myoblasts (Figure 4A). To confirm these
results, myoblasts were transfected with EV:F and Id2-3XFlag
fusion vectors and separated into nuclear and cytoplasmic
fractions (Figure 4B). Nuclear Id2 expression was significantly
greater in Id2:F and S5D:F transfected myoblasts compared to
S5A:F. The nuclear to cytoplasmic ratio Id2 was significantly
lower in Id2:F and S5A:F groups compared to an almost 1:1 ratio
in phospho-mimicking S5D groups (Figure 4C).
Although all forms of Id2 were present in both nuclear and
cytoplasmic protein fractions, phospho-ablated Id2 accumulated
in the cytoplasm. It has been shown that Id2 is actively removed
from the nucleus via a nuclear export receptor chromosome region
maintenance protein 1 (CRM1) dependent mechanism. [30] To
determine if the phosphorylation status of Id2 alters its nuclear
accumulation, myoblasts were treated with a CRM1 specific
Figure 3. Id2-3Xflag fusion proteins bind to E-proteins. (A) MyoD and E47 protein levels are not affected by the overexpression of Id2:F, S5A:F
or S5D:F compared to control EV:F in whole cell lysates. An anti-E12/E47 IP was performed with 500 mg of whole-cell lysates and anti-E47/E12
antibodies. The precipitates were blotted with anti-M2 flag monoclonal antibodies (B), and anti-Id2 polyclonal antibody (C). BD=bead only control;
CON=control C2C12; EV:F=Flag Empty Vector; Id2:F=Id2-Flag; S5A:F=Id2S5A-Flag; S5D:F=Id2S5D-Flag.
doi:10.1371/journal.pone.0006302.g003
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transfected with, EV:GFP, Id2:GFP, S5A:GFP, and S5D:GFP. Twenty-four hours after transfection, the nuclei were isolated and subjected to flow
cytometric analysis. [*, significantly different from CON, EV:GFP, and S5A:GFP; #, significantly different from all groups (p,0.05)] Insert: Histogram of
Histone (H2B) expression (Comparisons of negative control % and isolated nuclei & X-axis=log of mean fluorescence intensity (MFI) of H2B. Y-
axis=cell counts) (B) Nuclear flag expression is decreased in S5A:F transfected myoblasts. Nuclear (n) and cytoplasmic (c) Flag protein content was
determined by Western blot analysis. Data are expressed as optical density (OD)6resulting band area expressed in arbitrary units610
7. Insert:
representative blot for flag in Id2:F, S5A:F, and S5D:F transfected myoblasts. Controls for nuclear and cytoplasmic proteins were Lamin B and b-
tubulin respectively. Data are means6SE. *, significantly different from Nuclear flag. #, S5:F significantly different from all groups (p,0.05). (C) The
nuclear to cytoplasmic ratio of S5A:F is decreased in S5A:F transfected myoblasts. * #, significantly different from all groups (p,0.05). (D) LMB
treatment causes Id2 to accumulate in the nucleus. Twenty-four hours following transfection, cells were treated with LMB (5 ng/ml) for 60 min, and
separated into nuclear (n) and cytoplasmic (c) protein fractions as previously described.
doi:10.1371/journal.pone.0006302.g004
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of myoblasts with LMB (Figure 4D) resulted in an accumulation of
Id2:F, S5A:F, and S5D:F in the nuclear fraction. The initial time-
course experiments showed that prolonged exposure (3 hr) to
LMB resulted in significant cell death based on morphological
analysis (data not shown). As a result, these data were confirmed
by immunocytochemistry (Supplement Figure S2). These data
suggest that Id2 localizes to the nucleus, but phosphorylated Id2
may be retained in the nucleus. In contrast, phospho-ablated Id2,
and possibly unphosphorylated Id2 may be exported to the
cytoplasm under normal conditions when nuclear export is not
inhibited.
Phospho-ablated Id2 is pro-apoptotic in C2C12
myotubes
Muscle growth and repair from injury are dependent on the
ability of muscle precursor cells to proliferate, differentiate, and fuse
into myotubes, and eventually, myofibers. As a result, apoptosis of
myoblasts should inhibit myogenesis. The next experiment was
designed to determine if the phosphorylation status of Id2 affects
myoblast differentiation. C2C12 myoblasts were transfected with
EV:F, Id2:F, S5A:F, and S5D:F. Twenty-four hours after
transfection, the myoblasts were induced to differentiate by
switching from growth medium (GM) to differentiation medium
(DM). After 72 h in DM, MF20 immunostaining was performed,
and the proportion of myosin heavy chain (MHC)-positive cells and
the fusion index was measured as an indication of differentiation.
The overexpression of Id2:F, S5A:F, and S5D:F significantly
decreased the extent of myotube formation compared to control
cells (Figure 5A & Figure 5B). The myotube index was not different
between phospho-ablated Id2S5A and phospho-mimicking
Id2S5D; however, there was a significant (p,0.05) reduction in
total DAPI labeled nuclei(Figure 5A), as well asMF20 proteinlevels
(Figure 5C) in Id2S5A transfected cells. Pro-apoptotic caspase 3
activity levels were also significantly elevated in S5A:F transfected
myotubes. Together these data suggest that fewer myotubes
survived in the Id2S5A transfected group, and they were likely
eliminated via apoptotic regulated pathways. Nevertheless, the
Id2S5A-transfected cells that remained in the dish appeared to
differentiate normally.
Figure 5. Phospho-ablated Id2 is pro-apoptotic in C2C12 myotubes. C2C12 myoblasts were transfected with, EV:F, Id2:F, S5A:F, and S5D:F.
Twenty-four hours after transfection, cells were placed in DM and myotubes were harvested 72 hrs later. (A) Immunohistochemical staining of
myotubes (MF20: Red, DAPI: Blue). (B) Myotube fusion index is the number of nuclei within a myotube divided by the total number of nuclei. As
expected, the overexpression of Id2 delays myotube formation. [* significantly different from control EV:F (p,0.05): #, significantly different from
EV:F and Id2:F (p,0.05)]. (C) Representative blots for MF20, b-tubulin, and Flag in transfected myotubes. (D) Caspase 3 activity assay. [*, Significantly
different from all groups (p,0.05)].
doi:10.1371/journal.pone.0006302.g005
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A fraction of muscle precursor cells/myoblasts undergo
apoptosis in vivo during muscle growth and repair from injury
[31–33]; however, the mechanism regulating apoptosis during
myogenesis especially in mature non-diseased muscles is not
clearly understood. Previous research in our lab has shown a
positive correlation between Id2 protein levels and apoptotic
markers in aged skeletal muscle [22], as well as apoptosis induced
atrophy of skeletal muscles [34]. In the present study, we have
provided novel evidence that the phosphorylation status of Id2 is a
mediator of apoptosis in C2C12 myoblasts. Specifically, the
ectopic expression of phospho-ablated Id2 induced apoptosis in
proliferating C2C12 myoblasts. Furthermore, we confirmed that
Id2 overexpression reduces myogenic differentiation.
Phospho-ablated Id2 is growth inhibitory in C2C12
myoblasts
Skeletal muscle growth and regeneration/repair are critically
dependent on having an adequate pool of muscle precursor cells or
myoblasts. The identification and characterization of important
proteins that regulate the expansion and survival of myoblasts are
important for both increasing our understanding of myogenesis,
but also for identifying strategies that will reduce the loss of muscle
mass that occurs with aging and disease. Enhanced myoblast
proliferation could expand the number of myonuclei available for
myotube formation. Id2 contains a consensus phosphorylation site
(SPVR) for cyclin E/cdk2 and cyclin A/cdk2. Id2 is phosphor-
ylated by cyclin E/cdk2 complexes during late G1, which results in
a restoration of E-box transcriptional activity [15]. Our data
suggest that phosphorylation of Id2 at serine-5 has an important
role in regulation of myoblast proliferation.
In the current study, we found that the overexpression of Id2
increased the proliferation of C2C12 myoblasts. Conversely, we
found that phospho-ablated Id2 transfected myoblasts had a
significant decrease in S-phase entry. We speculate that the
proliferation capabilities of Id2 and S5A occur in part through
inhibition of p21 promoter activity. This hypothesis is consistent
with previous observations showing that the promoter activity of
p21 in rat aortic smooth muscle is not inhibited by phospho-
ablated Id2 [16]. We found that p21 promoter activity was
significantly decreased in myoblasts overexpressing Id2, and
increased in myoblasts overexpressing phospho-ablated Id2S5A
(Supplement Figure S3). Cyclin A is important for DNA
replication and progression through S phase, and it requires
cdk2 to enter the nucleus during prophase [35]. When Id2 is
overexpressed in A549 carcinoma cells, there is a decrease in
cyclin A promoter activity compared to control cells [13]. A
decrease of cyclin A protein levels in myoblasts would be expected
to decrease their proliferative capabilities. The possibility exists
that the phosphorylation status of Id2 may alter cell cycle
progression by regulating cyclin A expression. A prerequisite for
myotube formation is p21 expression and exit from the cell cycle.
This study is the first demonstration that Id2 phosphorylation
status determines the proliferative status of skeletal muscle
myoblasts. Similar results have been demonstrated in NIH3T3
cells, U2OS cells, and rat aortic smooth muscle cells [15,16]. It is
possible that the localization of Id2 may also be important in
regulating passage through S phase.
Phosphorylation and cellular localization of Id2
Id2 is primarily localized in the cytoplasm in skeletal muscle
tissue that is undergoing apoptosis-associated atrophy [26,27,36].
Our results suggest that overexpression of unphosphorylated Id2
in proliferating myoblasts is chiefly restricted to the cytosol, where
it may exert an apoptotic effect. A similar result was found in rat
aortic smooth muscle cells [16]. However, because Id2 is a small
protein, it can passively diffuse into the nucleus [30]. The C-
terminal region of Id2 contains a nuclear export signal, and
deletion of amino acids 103–109 result in nuclear localization [30].
Treatment of Id2 transfected NIH3T3 fibroblasts with a nuclear
export inhibitor LBM, was previously shown to result in an
accumulation of Id2 in the nucleus [30]. Interestingly, the
cytoplasmic localization of Id2 decreases its ability to repress
bHLH transcriptional activation of E-box promoter [30]. The
ectopic expression of E-proteins significantly upregulates cyclin
dependent kinase inhibitors (CDKI) p21, p15 and p16 and
increases cell death via apoptosis [37].
Phospho-ablated Id2 regulates apoptosis
Id2 has been shown to promote apoptosis in various cell types
[8]. The N-terminal region of Id2, which contains the consensus
cdk2 phosphorylation sequence SPVR, [15] has been shown to
promote apoptosis in 32D.3 myeloid cells through an association
with pro-apoptotic protein Bax [21]. During unloading-induced
muscle atrophy after hypertrophy in young adult birds, there is a
positive correlation between cytosolic Id2 protein levels and
apoptotic markers Bax and TUNEL. Conversely, there is a
negative correlation with the anti-apoptotic protein B-cell
leukemia/lymphoma 2 (Bcl2) and Id2 [26]. In the current study,
overexpression of phospho-ablated Id2 resulted in an increase in
several markers of apoptosis including: Annexin V, TUNEL,
caspase 3 and caspase 8 activities. Currently, the mechanism of
how Id2 activates apoptosis remains unknown, but it may function
through intrinsic (i.e., mitochondria) or extrinsic (i.e., death
receptor) pathways. Cytochrome c release has been shown to
activate processing of procaspase 8 into its active form [38,39].
The possibility exists that phospho-ablated Id2 interacts with the
death domain cascade, as caspase 8 has been shown to activate
caspase 3 in MDA-MB231 breast cancer cells treated with
etoposide [40]. Alternatively, the activation of caspase 8 that was
seen in our results, could be due to the intracellular processing of
procaspase 8 independent of the death receptor pathway, as
caspase 8 has been shown to be activated by caspase 3 and caspase
6 in Jurkat cells [41]. In MCF-7 human breast cancer cells, caspase
8 activation appears to be due to the activation of caspase 9 within
the apoptosome, as caspase 8 processing is inhibited by
overexpression of the anti-apoptotic protein Bcl2 [42].
Id2 phosphorylation status does not affect E47/E12
binding
Previous research has shown that Id2 preferentially forms
heterodimers with class A bHLH proteins E47/E12, which are
ubiquitously expressed throughout many different cell types [43].
MyoD, E12, and E47 are synthesized in the cytoplasm and
translocated into the nucleus via a nuclear localization signal
(NLS). Our results demonstrate that wild-type Id2, phospho-
ablated Id2 and phospho-mimicking Id2 successfully bind to E47/
E12 in C2C12 myoblasts. This suggests that Id2 binding to E
proteins is not affected by the phosphorylation status of Id2.
However, this does not rule out the possibility that Id2
phosphorylation might alter Id2:E protein function. For example,
the phosphorylation of Id2 at serine 5 has been shown to abolish
Id2’s inhibition of E12/MyoD/DNA complexes in vitro [15]. It is
likely that the apoptosis seen with phospho-ablated Id2 in C2C12
cells is not related to MyoD or bHLH proteins because, in 32d.3
myeloid cells, the overexpression of Id2 promotes apoptosis in a
dose dependent manner independent of bHLH binding [21].
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the amount of apoptosis [21]. In contrast, N-terminal deletions
exhibit no changes in amount of apoptosis compared to wild-type
Id2 transfectants based on Tunnel labeling and Bax expression
and an increased percentage of sub-diploid DNA content [21].
Our data are consistent with previous observations showing that
the phosphorylation of Id2 by protein kinase A and protein kinase
C does not alter Id2:E47/E12 heterodimers or inhibition of DNA
binding [44].
The phosphorylation status of Id2 at serine 5 alters
myotube formation and apoptosis
Id2 is a HLH protein that negatively regulates cell differenti-
ation in many cell types including skeletal muscle [8–11]. Id
proteins share a sequence homology with the second amphipathic
helix by other basic HLH (bHLH) proteins such as MyoD, E47,
and E12 [12]. The subcellular localization of MyoD and E47 are
predominantly nuclear despite their dimerization partner [45]. Id
proteins lack the basic N-terminal region needed for DNA binding
and inhibit myogenic differentiation by sequestering bHLH
proteins E47 and E12. Consistent with this role for Id2, we
observed that in proliferating myoblasts there is no detectible
binding of MyoD to the E47/E12. MyoD levels remained constant
even with the overexpression of Id2, phospho-ablated Id2S5A, and
phospho-mimicking Id2S5D. The cytosolic content of Id2 is
increased and is also positively correlated to apoptosis in rodent
and bird models of unloading-induced atrophy [26,27]. Both
mitotic and post-mitotic myonuclei are eliminated through
apoptosis-induced mechanisms in unloading-induced atrophy
[46]. Myotube formation was significantly reduced in the current
study by the overexpression of Id2, Id2S5A, and Id2S5D, and
there was a significant increase of caspase 3 activities in myotubes
overexpressing phospho-ablated Id2. Furthermore, there was a
decrease in the total number of nuclei in the myotubes
overexpressing Id2S5A. The reduction of myotube formation is
due to the combined effects of a decrease in proliferation and
enhanced apoptosis. In human diploid fibroblasts, the phosphor-
ylation of Id2 at serine 5 has been shown to abolish Id2’s inhibition
of E12/MyoD/DNA complexes in vitro [15]. In the present study,
myotubes that overexpressed phospho-mimicking Id2S5D had a
large number of unfused myonuclei as well as single cells
expressing MF20. Previously, Id2 has only been correlated to
apoptosis in skeletal muscle, and this is the first example of Id2
inducing apoptosis in myotubes. Future studies are needed to
determine the mechanism of how Id2 phosphorylation at serine 5
alters myotube formation, and to determine if Id2 induces
apoptosis in vivo.
In conclusion, our current data provide an explanation for
previous observations indicating that cytoplasmic levels of Id2 and
nuclear apoptosis are increased under conditions of muscle
wasting including sarcopenia [26,27]. In the present study, we
have provided novel evidence that the phosphorylation status of
Id2 is a mediator of apoptosis and cellular proliferation in C2C12
myoblasts. Specifically, the ectopic expression of phospho-ablated
Id2 induced decreased proliferation of C2C12 myoblasts, and
induced apoptosis. It is possible that muscle wasting increases
hypophosphorylated levels of Id2, which are confined to the
cytoplasmic spaces of muscle cells, and this initiates the increased
apoptosis seen under these conditions of muscle loss [26,27].
Future studies are however, needed to determine if the
phosphorylation status of Id2 at serine 5 alters apoptotic markers
seen during conditions of in vivo skeletal muscle loss including aging
and disuse-induced muscle wasting. This is important because
inhibition of apoptosis is likely to improve the number of precursor
cells [3] that are available to participate in regeneration and repair
of muscles following injury, or to improve muscle recovery
following aging-associated losses.
Materials and Methods
Plasmid constructs
For construction of the wild-type Id2 plasmids, cDNAs
encoding full-length murine Id2 were inserted into the Nde1/
HindIII sites of the pDNR-1r vector (BD Biosciences, Palo Alto,
CA, USA). Complementary DNA (cDNA) was reverse transcribed
from RNA containing high levels of the Id2 transcript [47]. The
forward primer (59tccctcccggcctttcctccta39) and the reverse primer
(59ccggagacacctggggagatgatc39) generated a 650 bp product,
which was used as a cDNA template for a second set of Id2
primers producing a 434-bp product. The forward primer
(59cctacgagccatatgaaagccttcag39) contained an NdeI restriction
site. The reverse primer (59tccccaaataagcttttattagccacagagtactt39)
contained a hind III restriction site. The 434-bp Id2-PCR product
was sequenced (SeqWright, Houston, TX, USA), and then
subcloned into the pDNR-1r vector. The Id2-pDNR-1r vector
was recombined with a pLP-IRES-eGFP vector (BD Biosciences)
to generate an enhanced green fluorescent protein (GFP)
expression vector (Id2:GFP) 6807-bp. For control experiments,
the pDNR-1r vector was recombined with the pLP-IRES-eGFP
vector to generate an empty GFP expression vector (EV:GFP).
The IRES sequence in the Id2:GFP and EV:GFP vectors
permitted both the wild-type Id2 gene, and the GFP gene to be
translated from a single bicistronic mRNA. The EV:GFP vector
only produced GFP.
Site directed mutagenesis
The Id2-pDNR-1r vector was mutated with the QuickChange
Site-Directed Mutagenesis kit (Stratagene, La Jolla, CA, USA) as
suggested by the manufacturer. Phospho-ablated Id2 mutants
(S5A) and phospho-mimicking Id2 mutants (S5D) were generated
by changing serine 5 to alanine 5 and aspartic acid 5, respectively.
The S5A forward and reverse mutant primers were 59gaccatat-
gaaagccttcgcaccggtgaggt ccgtg39 (mutation site is underlined), and
59cctaacggacctcaccggtgcgaaggcttycatatc39, respectively. The S5D
forward and reverse primers were 59gaccatatgaaagccttcgacccggt-
gaggtccgtg39, and 59cctaacggacctcaccgggtcgaaggctttca tatc39, cor-
respondingly. Id2, S5A, and S5D were cloned into pLP-IRES-
eGFP as described above. C-terminal fusion proteins were also
made by subcloning Id2, S5A, and S5D into p3XFlag-CMV-14
(Sigma-Aldrich, St. Louis, MO, USA) to yield Id2-flag (Id2:F),
S5A-flag (S5A:F), and S5D-flag (S5D:F). An empty p3XFlag-
CMV-14 (EV:F) vector was used as a control for flag experiments.
Culture conditions for C2C12 myoblasts
C2C12 myoblasts (ATCC, Manassas, VA, USA) were main-
tained in growth medium (GM) consisting of Dulbecco’s modified
Eagle’s medium supplemented with 10% FBS, 100 U/ml
penicillin G, 100 mg/ml streptomycin, and 0.25 mg/ml ampho-
tericin fungizone. The cells were incubated at 37uC in a water-
saturated atmosphere of 95% ambient air and 5% CO2.
Subsequent experiments were performed when the cells reached
a density of approximately 70%.
Electroporation-induced transfection of C2C12 myoblasts
C2C12 myoblasts were suspended in trypsin, centrifuged, and
then resuspended in 100 ml of electroporation buffer (88 mM
KH2PO4, 14 mM NaHCO3, 2.2 mM glucose, 14.6 mM ATP,
and 23.5 mM MgCl2). Approximately 2610
6 cells per sample
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cuvette (BioRad, Hercules, CA, USA), with four 200 V pulses
each lasting 5 ms duration. After the electroporation, the cells
were resuspended in 500 ml of minimal essential medium (ATCC,
Manassas, VA, USA) for 5 min at 37uC. The cells were then
plated into 10 cm plates with GM, and incubated in 5% CO2-
95% air at 37uC, and then harvested 24 hrs later.
Analysis by flow cytometry
Approximately 5610
5 C2C12 myoblasts per sample were used
for antibody staining and cell cycle analysis. The adherent cells
were harvested with trypsin, washed in 16 phosphate buffered
saline (PBS), collected by centrifugation, and fixed with 4%
paraformaldehyde. The cells were washed in PBS, and then
incubated in permeabilization buffer (PB; 16 PBS containing
0.5% BSA, 0.025% TritonX), and collected by centrifugation. The
cells were resuspended in PB containing an antibody to: Id2 (BD
Biosciences, San Jose, CA USA), E47/E12, (BD Biosciences),
MyoD (Santa Cruz, Santa Cruz, CA, USA), or M2 flag (Sigma-
Aldrich) diluted at a final concentration of 1:50 for 30 min at room
temp. The cells were washed and incubated for 1 h in an
appropriate secondary antibody [Alexa FluorH 488, 546 goat anti-
rabbit or mouse IgG, (Molecular Probes, Eugene, OR, USA); Cy5
Donkey anti-rabbit IgG (Jackson ImmunoResearch, West Grove,
PA, USA); PE-Cy5 goat anti-mouse IgG1 (BD Biosciences)].
Negative controls were incubated without primary antibodies.
After washing, the cells were collected by centrifugation, and
resuspended in 400 ml of PB. Data acquisition and analysis were
performed on a FACSCalibur
TM Flow Cytometer using CellQuest
Pro software (BD Biosciences). All data are represented as mean
fluorescence intensity (MFI). Additional cell cycle modeling was
performed using Modfit LT software (Verity Software House, Inc.
ME, USA).
TdT-mediated dUTP nick end labeling
DNA fragmentation of individual cells was detected in situ by a
fluorescein labeled TdT-mediated dUTP nick end labeling
(TUNEL) kit according to the manufactures directions (Roche,
Philadelphia, PA, USA).
Nuclear isolation
Adherent cells were harvested in trypsin, and washed twice in
16PBS. The nuclei were isolated in 200 ml of Pipes-Triton Buffer
(10 mM Pipes, 0.1 M NaCl, 2 mM MgCl2, and 0.1% Tri-
ton6100) per 2610
5 cells, and incubated for 30 min at 4uC. The
nuclei were washed in PBS containing 1% BSA, centrifuged at
3000 rpm then stained with antibodies to flag-Cy3 or Id2, at a
final concentration of 1:50. The nuclei were washed in PB then
incubated in PE-Cy5 goat anti-mouse IgG1 at a concentration of
1:500. The nuclei were washed in PB, and resuspended in 500 ml
of 1% PB containing 1 mg of propidium. Id2-Cy5 and Flag-Cy3
mean fluorescent intensity were measured by flow cytometry.
Fluorometric caspase activity assay
Caspase activities were measured as previously reported
[25,48]. In brief, the total protein fraction (50 ml) without protease
inhibitor of transfected C2C12 myoblasts was incubated in 50 ml
of assay buffer (50 mM PIPES, 0.1 mM EDTA, 10% glycerol, and
10 mM DTT, pH 7.2) with 50 mM of the fluorogenic 7-amino-4-
trifluoromethyl coumarin (AFC)-conjugated substrate (Ac-DEVD-
AFC for caspase 3, IETD-AMC for caspase 8; Alexis, San Diego,
CA) at 37uC for 2 h. The change in fluorescence was measured on
a spectrofluorometer (CytoFluor; Applied Biosystems, Foster City,
CA, USA) with an excitation wavelength of 390/20 nm and an
emission wavelength of 530/25 nm before and after the 2-h
incubation. Caspase activity was estimated as the change in
arbitrary fluorescence units normalized to milligrams of protein
used in the assay. Control and experimental samples were run on
the same microplate in the same setting.
Immunoprecipitation of Id2
Cells were harvested and homogenized in CHAPS buffer
(40 mM HEPES (pH 7.5), 20 nM NaCl, 1 mM EDTA, 10 mM
pyrophosphate, 10 mM b-glycerolphosphate, 40 mM NaF,
1.5 mM sodium vanadate, 0.3% CHAPS, 0.1 mM PMSF,
1 mM benzamidine, and 1 mM DTT). The resulting homogenate
was centrifuged at 1000 g to obtain the supernatant. 500 mgo f
supernatant protein was combined with 5.8 ml of anti-flag M2
antibody and mixed overnight at 4uC. The immune complexes
were isolated using a goat anti-mouse BioMag IgG (PerSeptive
Diagnostics, Cambridge, MA, USA) bead slurry. The beads were
blocked with 0.1% nonfat dry milk in CHAPS buffer, washed in
CHAPS buffer, and then incubated with the sample for 1 hr at
4uC. The beads were collected using a magnetic stand, washed in
CHAPS buffer containing 120 mM NaCl and 40 mM HEPES,
and then in CHAPS buffer containing 200 mM NaCl and 60 mM
HEPES. The precipitates were eluted in sample Laemelli buffer
containing sodium dodecyl sulfate (SDS) and then boiled for
5 min. The beads were pelleted by centrifugation; the supernatant
was collected and subjected to sodium dodecyl sulfate polyacryl-
amide gel electrophoresis (SDS-PAGE). The proteins were
transferred to nitrocellulose membranes, incubated in antibodies
to flag M2, Id2, E47/E12, or MyoD. The resulting bands were
visualized with ECL Advance (Amersham Biosciences, Piscataway,
NJ, USA), and exposed to X-Ray film.
Protein Isolation and Western Blots
C2C12 myoblasts were washed with PBS at room temperature.
C2C12 cells were lysed at 4uC with 150 mlo f1 6 SDS sample
buffer, then centrifuged at 10,0006g to obtain the total cellular
lysate. The supernatant contained the total cell lysate. A RC/DC
Protein Assay (BioRad) was used to determine protein concentra-
tions according to manufactures directions. For cell fractionation
experiments, cells were harvested according to methods described
previously in our lab [25–27]. The protein concentration of each
lysate was detected by a DC Protein Assay Kit (BioRad) according
to manufacturer’s directions. 40 mg of protein extracts were
separated by 18% SDS-PAGE, transferred to a nitrocellulose
membrane, and then probed with antibodies against Id2, M2 Flag,
E47, or b-tubulin. ECL Advance (Amersham Biosciences) was
used to detect the immunopositive bands by chemiluminescence.
Immunohistochemistry
The cells were grown on glass coverslips, fixed for 1 hr in 2%
paraformaldehyde, washed in PBS then permeabilized with 0.1%
TritionX-100. The coverslips were incubated at 20uC for 1 hr in
with an antibody to M2 flag (Sigma-Aldrich). The cells were
washed and incubated for 1 hr in an Alexa FluorH 546 goat anti-
mouse IgG secondary antibody (Invitrogen, Carlsbad, CA, USA).
The coverslips were washed and mounted in a medium containing
49,6-diamidino-2-phenylindole (DAPI; Vector Laboratories, Bur-
lingame, CA, USA) to indentify the nuclei.
Statistical Analyses
Statistical analyses were performed using the SPSS 10 software
package. One way analysis of variance (ANOVA) was used to
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EV:GFP, and Id2:GFP, S5A:GFP, S5D:GFP, EV:F, Id2:F, S5A:F,
and S5D:F transfected myoblasts. A minimum of three separate
trials were completed for each experiment. Statistical significance
was accepted at P,0.05. All data are given as means6standard
error of the mean (SE).
Supporting Information
Figure S1 Detection of Id2-3XFlag fusion proteins. CON=control
C2C12; EV=Flag empty vector; Id2=Id2-Flag; S5A=Id2S5A-
Flag; S5D=Id2S5D-Flag. (A) Y-axis=side scatter, x-axis=Flag
MFI. (B) Double labeling of Id2 and flag. As expected, flag positive
myoblasts are also Id2 positive. (y-axis=Flag MFI, x-axis=Id2
MFI) (C) Id2 MFI. The MFI of Id2 was significantly (p,0.05)
elevated in Id2, S5A, and S5D transfected myoblasts compare to
control samples.
Found at: doi:10.1371/journal.pone.0006302.s001 (2.66 MB TIF)
Figure S2 LMB treatment causes Id2 to accumulate in the nucleus.
Twenty-four hours following transfection, cells were treated with (+)
LMB (5 ng/ml) or vehicle (2) for 60 min, and immunohistochem-
ical staining of M2Flag was performed (Flag: Red, DAPI: Blue).
Found at: doi:10.1371/journal.pone.0006302.s002 (2.56 MB TIF)
Figure S3 p21promoter activity is decreased by Id2. A p21p-pGL2-
luciferase reporter plasmid containing the promoter of human
p21/WAF1 between positions 22,300 and +8 or pGL2-empty
vector was cotransfected with CON, EV:F, Id2:F, S5A:F, and
S5D:F. Twenty-four hours after transfection, a commercially
available luciferase assay system from Promega was used to assess
luciferase activity. Cells were lysed in passive lysis buffer as
supplied by the manufacturer, and 20 mg of the cell lysate was
assayed for luciferase activity using a standard luminometer. [*
significantly different from control CON, EV:F and S5A:F
(p,0.05 )]
Found at: doi:10.1371/journal.pone.0006302.s003 (1.41 MB TIF)
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